AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
JAVMA news
Longtime canine epilepsy treatment gains conditional approval
Food and Drug Administration officials granted conditional approval of a chewable potassium bromide tablet, KBroVet-CA1, for the control of seizures…
JAVMA news
Groups provide new guidance on antimicrobials
The AVMA, Canadian VMA, and Federation of Veterinarians of Europe are calling for continuous monitoring of antimicrobial use and resistance at a…
policy
Regenerative medicine, including therapeutic use of stem cells
Regenerative medicine holds promise in treating a variety of diseases, yet questions remain. The AVMA supports the continued scientific development of…
JAVMA news
Assessing pet supplements
A third of all U.S. households with dogs use supplements, as do about a fifth of households with cats, according to a report on pet supplements from…
JAVMA news
Supplement companies made changes after facing crackdown
The availability of glucosamine for animals seemed to be in question 15 years ago.
policy
Guidelines for use of autogenous biologics
Autogenous biological products may provide veterinarians a unique opportunity for control of certain infectious diseases when USDA-licensed commercial…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
JAVMA news
Drug's sale halted over arsenic concerns
A pharmaceutical company planned to halt sales of a drug used to treat a parasitic disease and increase growth in chickens after it was found that use…
JAVMA news
Extralabel drug substitution runs afoul of law
Extralabel use of drugs can give veterinarians effective options in treating patients, but there are limitations veterinarians should be aware of when…